2 ASX giants to buy and hold for the next 20 years

Looking for the best shares to buy and hold? Here are two blue chips to consider.

| More on:
A young well-dressed couple at a luxury resort celebrate successful life choices.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL stands as a beacon of resilience and growth in global healthcare, leveraging ageing demographics and rising healthcare needs to continually invest in research and expand its product offerings, promising long-term value for patient investors.
  • Goodman Group capitalises on the surging demand for industrial and logistics spaces crucial for e-commerce and AI, backed by strategic partnerships like its recent A$14 billion European data centre project with the Canada Pension Plan Investment Board.
  • Both CSL and Goodman offer compelling investment cases with their sustainable advantages and expansive market reach, poised to benefit from long-term trends in healthcare and digital infrastructure over the next two decades.

Trying to predict what the share market will do next week, next month, and next year is hard enough. Trying to forecast the next two decades can feel impossible.

That's why long-term investing is often about identifying businesses with sustainable advantages, massive addressable markets, and management teams that know how to compound value over time. If you get those elements right, short-term volatility becomes little more than background noise.

With that in mind, here are two ASX giants that I believe have the qualities required to still be thriving and potentially much larger 20 years from now.

CSL Ltd (ASX: CSL)

CSL might have been out of form in 2025, but it remains one of Australia's greatest corporate success stories and its long-term investment case remains compelling.

The company sits at the centre of global healthcare, specialising in plasma-derived therapies, vaccines, and biotechnology. Demand for CSL's products is driven by powerful structural trends, including ageing populations, improving diagnosis rates, and rising healthcare spending across developed and emerging markets.

What makes CSL especially attractive for long-term investors is its ability to reinvest heavily while still generating strong cash flows. The company consistently pours billions into research and development, facilities, and acquisitions to strengthen its pipeline and widen its moat. Importantly, these investments are designed to deliver returns over decades, not quarters.

While CSL's share price can go through periods of consolidation or weakness, such as in 2025, its underlying business has proven remarkably resilient across economic cycles. Over a 20-year timeframe, that consistency, combined with compounding earnings growth, is exactly what patient investors should be looking for. So, with its shares down heavily over the past 12 months, I think now could be an opportune time to make a long-term investment.

Goodman Group (ASX: GMG)

Goodman Group may be classified as a property stock, but it operates very differently to traditional real estate businesses.

Rather than shopping centres or offices, this ASX giant focuses on high-quality industrial property, logistics hubs, and data-enabled warehouses. These assets sit at the heart of global supply chains and are critical infrastructure for e-commerce, automation, and artificial intelligence.

Goodman's edge comes from its development expertise and global footprint. It works closely with major customers to design and build customised facilities, locking in long-term relationships while earning development profits and recurring rental income. This capital-light model has allowed the company to grow rapidly without overloading its balance sheet.

An example of this is the agreement it signed with the Canada Pension Plan Investment Board this month. This will see it establish a A$14 billion European data centre partnership comprising four projects totalling 435 MW of primary power and 282 MW of IT load.

Looking ahead, the growth of online retail, cloud computing, and AI-driven logistics should keep demand for Goodman's assets strong for many years. Its exposure to data centres adds another long runway, as digital infrastructure becomes as essential as roads and ports.

Motley Fool contributor James Mickleboro has positions in CSL and Goodman Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goodman Group. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

Here's an ASX 200 share that I think could beat Westpac in 2026

This growth share could be a great pick. Here's why.

Read more »

Blue chip in a trolley with a man pushing it.
Cheap Shares

3 beaten-down ASX 200 shares to pick up in February

These beaten-down ASX 200 shares are nearing 52-week lows with upcoming results that could shift sentiment.

Read more »

Three shareholders climbing ladders up into the clouds.
Blue Chip Shares

Are these the best blue-chip ASX shares money can buy?

These are businesses I’d feel comfortable owning regardless of market conditions.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses have appealing qualities...

Read more »

Buy and sell written on a white cube.
52-Week Lows

3 ASX 200 shares worth buying after February's sell-off

February’s sell-off has dragged several ASX 200 growth shares back to more attractive levels.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Blue Chip Shares

Ord Minnett has a 'strongly positive view' on this ASX 200 star

The broker has good things to say about this blue chip.

Read more »

A warehouse worker is standing next to a shelf and using a digital tablet.
Retail Shares

Are Wesfarmers shares a buy for passive income?

The outlook for the blue-chip stock is solid, but far from spectacular.

Read more »

A woman standing on the street looks through binoculars.
Blue Chip Shares

Which ASX shares benefit from a stronger AUD?

Where should investors look with a strengthening AUD?

Read more »